Patents
Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320)
10/1999
10/05/1999CA2161962C Adenovirus vectors for gene therapy
10/05/1999CA2074182C Process for the reactivation of denatured protein
10/01/1999CA2249043A1 Novel compounds
09/1999
09/30/1999WO1999049316A2 Peripheral-type benzodiazepine receptor: a tool for detection, diagnosis, prognosis, and treatment of cancer
09/30/1999WO1999049055A1 Human casb12 polypeptide, a serine protease
09/30/1999WO1999049044A1 Cardiostatin polypeptides and polynucleotides
09/30/1999WO1999049042A1 HUMAN Rad1 CELL CYCLE CHECKPOINT
09/30/1999WO1999049040A1 HUMAN G-PROTEIN COUPLED RECEPTOR GPR6sb
09/30/1999WO1999049039A2 GFRα3 AND ITS USES
09/30/1999WO1999049038A2 Human calcium-binding proteins
09/30/1999WO1999049037A2 Protein phosphatase-related molecules
09/30/1999WO1999049033A1 Casb414: antigen overexpressed in several tumors
09/30/1999WO1999049032A1 Suppressors of cytokine signalling
09/30/1999WO1999049023A1 The cytokine family member 2-21
09/30/1999WO1999049019A2 Luciferases, fluorescent proteins, nucleic acids encoding the luciferases and fluorescent proteins and the use thereof in diagnostics
09/30/1999WO1999048927A1 Methods for designing specific ion channel blockers
09/30/1999WO1999048926A1 ANTIBODY AGAINST HUMAN α1,3-FUCOSE TRANSFERASE Fuc-TVII
09/30/1999WO1999048925A1 Methods for identifying inducers and inhibitors of proteolytic antibodies, compositions and their uses
09/30/1999WO1999048921A1 Novel mammalian g-protein coupled receptors having extracellular leucine rich repeat regions
09/30/1999WO1999048920A1 Novel physiologically active peptides and utilization thereof
09/30/1999WO1999048916A2 Hypoxia-inducible human genes, proteins, and uses thereof
09/30/1999WO1999048527A1 Apo-2 ligand-anti-her-2 antibody synergism
09/30/1999WO1999048523A2 Antagonists of the inflammatory mediator oncostatin m (osm)
09/30/1999WO1999048521A1 Sciellin and uses thereof
09/30/1999WO1999048513A1 Methods and compositions for peptide synthesis
09/30/1999WO1999048509A1 Urokinase plasminogen activator receptor as a target for diagnosis of metastases
09/30/1999WO1999048508A1 Treatment of ulcerative colitis with tropomyosin isoforms and monoclonal antibodies to tropomyosin isoforms
09/30/1999WO1999048478A1 Use of glycosaminoglycans degrading enzymes for management of airway associated diseases
09/30/1999WO1999042478A3 LEPTOSPIRAL OUTER MEMBRANE PROTEIN, LipL32
09/30/1999WO1999041387A3 Prostate-associated serine protease
09/30/1999WO1999038532A3 Methods for the prevention and treatment of fibrosis and sclerosis
09/30/1999WO1999037788A3 Diagnosis and treatment of aur1 and/or aur2 related disorders
09/30/1999WO1999035266A3 Human urotensin ii
09/30/1999WO1999035246A9 Novel steroid-activated nuclear receptors and uses therefor
09/30/1999WO1999032519A9 Novel g protein-coupled receptor
09/30/1999WO1998018824A9 Human tumor necrosis factor receptor-like 2
09/30/1999DE19813048A1 Nucleic acids useful for identifying compounds capable of inducing pathogen resistance in plants
09/30/1999CA2325585A1 Inflammatory mediator antagonists
09/30/1999CA2324648A1 Luciferases, fluorescent proteins, nucleic acids encoding the luciferases and fluorescent proteins and the use thereof in diagnostics, high throughput screening and novelty items
09/30/1999CA2324494A1 Apo-2 ligand-anti-her-2 antibody synergism
09/30/1999CA2324340A1 Methods for identifying inducers and inhibitors of proteolytic antibodies, compositions and their uses
09/30/1999CA2323760A1 Human casb12 polypeptide, a serine protease
09/30/1999CA2323640A1 Human calcium-binding proteins
09/30/1999CA2323605A1 Protein phosphatase-related molecules
09/30/1999CA2323601A1 Casb414: antigen overexpressed in several tumors
09/30/1999CA2322843A1 Hypoxia-inducible human genes, proteins, and uses thereof
09/29/1999EP0945512A2 Novel serine proteases
09/29/1999EP0945506A1 Novel peptide, novel dna, and novel antibody
09/29/1999EP0945465A1 Antagonistic monoclonal antibodies to human CD40
09/29/1999EP0945464A1 Specific binding members for human transforming growth factor beta; materials and methods
09/29/1999EP0944837A1 Methods and reagents for determining protein s
09/29/1999EP0944833A2 Sandwich assays for collagen type i fragments
09/29/1999EP0944725A1 Phosphodiesterase 8a
09/29/1999EP0944723A2 Mammalian chemokines
09/29/1999EP0944722A2 Pituitary-tumor-transforming-genes, and related products
09/29/1999EP0944721A1 Adipocyte-specific differentiation-related protein
09/29/1999EP0944720A1 Adaptor protein frs2 and related products and methods
09/29/1999EP0944651A2 Genes amplified in cancer cells
09/29/1999EP0944649A1 METHYLATED, SmD HOMOLOGOUS PEPTIDES, REACTIVE WITH THE ANTIBODIES FROM SERA OF LIVING BEINGS AFFECTED WITH SYSTEMIC LUPUS ERYTHEMATOSUS
09/29/1999EP0944394A1 Treatment of hiv-infection by interfering with host cell cyclophilin receptor activity
09/29/1999EP0781414A4 Diagnostic test for proliferative senescence in immune cells
09/29/1999EP0474645B1 Protein complex
09/29/1999CN1230222A PTX-sensitive G proteins, prodn. and use thereof
09/29/1999CN1230216A Cleavable signal element device and method
09/29/1999CN1230198A Therapeutic multispecific compounds comprised of anti-FC'alpha' receptor antibodies
09/29/1999CN1230197A Subunit respiratory syncytial virus vaccine prepn.
09/29/1999CN1230195A Treatment of immune disorders
09/29/1999CN1229677A Composition and methods using nitroxides to avoid oxygen toxicity
09/28/1999US5959177 Transgenic plants expressing assembled secretory antibodies
09/28/1999US5959087 The ligand is preferably an antibody, f(ab) fragment, single domain antibody (dabs) single chain antibody or a serum binding protein.
09/28/1999US5959086 The present invention relates to proteins associated with acute pancreatitis and agents for the diagnosis of this disease.
09/28/1999US5959085 Human monoclonal antibodies against human cytokines and methods of making and using such antibodies
09/28/1999US5959084 Bispecific antibodies, methods of production and uses thereof
09/28/1999US5959083 Tetravalent bispecific receptors, the preparation and use thereof
09/28/1999US5959079 CREBA isoform
09/28/1999US5959075 Testis-specific insulin homolog polypeptides
09/28/1999US5958880 Feline Fc epsilon receptor alpha chain proteins and therapeutic uses thereof
09/28/1999US5958765 For producing human monoclonal antibodies which are specific to respiratory syncytial virus and in particular the rsv fusion (f) protein
09/28/1999US5958736 Recombinant DNA coding for signal peptide, selective interacting polypeptide and membrane anchoring sequence
09/28/1999US5958735 Polynucleotides encoding urogenital sinus derived growth inhibitory factor and vectors
09/28/1999US5958731 Cell junction PDZ protein
09/28/1999US5958725 Human DP1 homolog
09/28/1999US5958723 DNA encoding prostaglandin receptor DP
09/28/1999US5958720 Mch2, an apoptotic cysteine protease, and compositions for making and methods of using the same
09/28/1999US5958712 Identifying altered t cell receptor ligand comprising major histocompatible complex and peptide that inhibits t cell effector response
09/28/1999US5958708 The molecules of the invention are useful for diagnostics, prophylaxis and treatment of allergy.
09/28/1999US5958705 Cytoplasmic modulators of integrin regulation/signaling
09/28/1999US5958699 Hybridization probe comprising polynulceotide encoding polypeptide; for identifying and encoding nucleic acid and amino acid sequences and using them for diagnosis, prevention, and treatment of intestinal diseases including cancer
09/28/1999US5958684 Diagnosis of neurodegenerative disease
09/28/1999US5958424 Recombinant chicken anemia virus particle
09/28/1999US5958413 Pharmaceutical product for use in therapy or prophylaxis of disorders associated with elevated tumor necrosis factor levels, especially septic shock or endotoxic shock
09/28/1999US5958412 Administering conjugate of antibody and anti-cancer drug, where in antibody is specific for a33 antigen for promoting colon or gastric cancer regression
09/28/1999US5958411 Methods of inhibiting ECM accumulation in the CNS by inhibition of TGF-β
09/28/1999US5958410 Administering monoclonal antibody specific for epitope of variable region of specified t cell receptor chain
09/28/1999US5958409 Administering antitumor necrosis factor antibody to the human suffering with multiple sclerosis
09/28/1999US5958405 Human protein tyrosine kinase
09/28/1999US5958402 Antitumor therapy using ovine or bovine interferon-tau
09/28/1999CA2088354C Pancreas-elastasis-1-specific antibody, a process for obtaining it and a test kit containing such antibodies
09/26/1999CA2264260A1 Polynucleotide molecules encoding neospora proteins
09/24/1999CA2249660A1 Novel compounds